AEMD
AETHLON MEDICAL INC
+5.59 (+390.91%)7.02USD81.1M成交股數5.0M市值0.3本益比(近四季)–股價營收比+2.5%營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 3 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 31K+2% | – | 44K-54% | 23K | 31K | 60K | 95K | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 549K | 561K | 533K | 294K | 524K | 240K | 261K | 415K | 619K | 593K | 628K | 679K |
| 銷售管理費用 | 662K | 698K | 742K | 521K | 735K | 816K | 958K | 752K | 765K | 979K | 851K | 1.3M |
| 營業利益 | −1.6M-12% | −1.9M+6% | −2.1M-29% | −1.5M-42% | −1.8M-28% | −1.8M-49% | −2.9M-9% | −2.6M-23% | −2.5M | −3.6M | −3.2M | −3.4M |
| 營業利益率 | -5,047.0% | – | -4,700.4% | -6,642.5% | -5,870.5% | -3,026.4% | -3,050.2% | – | – | – | – | – |
| 稅後淨利 | −1.5M-12% | −1.9M+7% | −2.0M-28% | −1.5M-42% | −1.8M-27% | −1.8M-49% | −2.8M-7% | −2.6M-22% | −2.4M | −3.5M | −3.0M | −3.3M |
| 淨利率 | -4,947.0% | – | -4,600.4% | -6,542.5% | -5,770.5% | -2,926.4% | -2,950.2% | – | – | – | – | – |
| 稀釋 EPS | -4.02-91% | 38.00-478% | -2.45-85% | -3.74+36% | -42.42+21% | -10.05+634% | -16.11+1220% | -2.76+104% | -34.93 | -1.37 | -1.22 | -1.35 |
| 稀釋股數 | 385K | 674K | 823K | 398K | 41.5K | 175K | 174K | 932K | 314K | 2.5M | 2.5M | 2.4M |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.9M | 5.0M | 7.0M | 5.9M | 3.8M | 4.8M | 6.9M | 9.1M | 5.4M | 8.0M | 10.2M | 12.9M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 6.2M | 6.3M | 8.1M | 7.3M | 5.3M | 6.5M | 8.8M | 11.4M | 8.2M | 10.4M | 12.8M | 15.8M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | – | 1.4M | 1.3M | 1.6M | 1.9M | 2.2M | 2.8M | 2.7M | 2.5M | 2.8M | 2.5M | 2.7M |
| 股東權益 | 5.2M | 4.9M | 6.7M | 5.7M | 3.4M | 4.3M | 6.0M | 8.7M | 5.8M | 7.6M | 10.3M | 13.1M |
| 負債比 | – | 22.8% | 16.7% | 21.5% | 35.5% | 33.6% | 32.0% | 23.7% | 30.1% | 27.1% | 19.6% | 17.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −1.9M+11% | – | – | – | −1.7M | – | – | −1.7M-30% | – | – | – | −2.5M |
| 資本支出 | 9K | – | – | – | 0.00 | – | – | 0.00 | – | – | – | 230K |
| 自由現金流 | −1.9M+11% | – | – | – | −1.7M | – | – | −1.7M-36% | – | – | – | −2.7M |
| 折舊攤銷 | 73K | – | – | – | 83K | – | – | 86K | – | – | – | 90K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | -6,090.4% | – | – | – | -5,616.9% | – | – | – | – | – | – | – |
營收拆解 2022 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2022 年度 · 294K
| Govt Contract And Grant Revenue | 294K | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | – | – | −7.2M | –% | -10.61 | −7.0M |
| FY2025 | – | – | −13.4M | –% | -85.77 | −7.6M |
| FY2024 | 0.00 | -100.0% | −12.2M | –% | -38.87 | −10.4M |
| FY2023 | 574K | +95.2% | −12.0M | -2,094.9% | -5.86 | −11.4M |
| FY2022 | 294K | -55.4% | −10.4M | -3,540.9% | -0.71 | −10.1M |
| FY2021 | 659K | +1.4% | −7.9M | -1,196.6% | -0.65 | −6.8M |
| FY2020 | 650K | +183.2% | −6.4M | -980.3% | -1.87 | −5.3M |
| FY2019 | 230K | – | −6.2M | -2,697.8% | -5.13 | −4.3M |